The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Settlement reached with the FHFA re US RMBS claims

12 Jul 2017 13:34

RNS Number : 8869K
Royal Bank of Scotland Group PLC
12 July 2017
 

The Royal Bank of Scotland Group plc

 

Settlement reached with the Federal Housing Finance Agency regarding US RMBS claims

 

12 July 2017

 

 

The Royal Bank of Scotland Group plc (together with its subsidiaries, "RBS") has reached a settlement with the Federal Housing Finance Agency ("FHFA") as conservator of Fannie Mae and Freddie Mac, to resolve claims by FHFA in relation to RBS's issuance and underwriting of approximately US$32 billion (£25 billion) of residential mortgage-backed securities ("RMBS") in the US.  As part of the settlement, FHFA's outstanding litigation against RBS will be withdrawn. 

Ross McEwan, RBS CEO, said:

 

"Today's announcement is an important step forward in resolving one of the most significant legacy matters facing RBS and is further evidence of the determination of the bank's leadership to put our remaining issues behind us.

 

"This settlement is a stark reminder of what happened to this bank before the financial crisis, and the heavy price paid for its pursuit of global ambitions."

 

Financial Impact of the FHFA settlement

 

Under the settlement, RBS will pay FHFA US$5.5 billion (£4.2 billion), of which US$754 million (£581 million) will be reimbursed to RBS under indemnification agreements with third parties.

 

The cost to RBS (net of the indemnity mentioned above) of US$4.75 billion (£3.65 billion) is largely covered by existing provisions. An incremental charge of US$196 million (£151 million) will be recorded in the RBS Q2 2017 results which will be published on 4 August 2017.

 

As at end Q1 2017, RBS held a provision of US$8.3 billion (£6.6 billion) against RMBS, of which $4.55 billion (£3.6 billion) related to FHFA and the remainder principally relates to a number of the matters described below.

 

 

Ongoing Legacy Inquiries and Litigation

 

RBS is one of 17 financial institutions to have settled RMBS claims filed by FHFA. Following this settlement, RBS's unresolved RMBS litigation matters involve the issuance of less than US $1 billion of RMBS issued primarily from 2005 to 2007, assuming court approval of an agreed and provided for settlement. This unresolved amount does not include the FHFA case involving RMBS issued by Nomura, which RBS estimates its net exposure as approximately US $383 million (£295 million) and intends to pursue indemnification for. This net exposure was also included within RMBS related provisions as at Q1 2017.

 

As previously disclosed, RBS continues to cooperate with RMBS related investigations and proceedings (both formal and informal) by federal and state governmental law enforcement and other agencies including the US Department of Justice ("DOJ") and various other members of the RMBS Working Group of the US Financial Fraud Enforcement Task Force. The duration and outcome of these investigations, including in particular the DOJ's civil and criminal investigations, and other RMBS litigation matters remain uncertain, including in respect of whether settlements for all or any of such matters may be reached.

 

RBS is not making any other adjustments to existing provisions relating to RMBS matters as a result of today's settlement but continues to advise that further substantial provisions and costs may be recognised and, depending upon the final outcomes, other adverse consequences may occur. Please see RBS's 2016 Annual Report and Accounts for further information on these outstanding investigations and litigation matters.

 

Investor call

 

Ewen Stevenson (Chief Financial Officer) will host a conference call for investors and analysts at 14.30 BST. A replay of the call will be made available shortly afterwards. Only items relating to the above announcement will be discussed on the call; there will be no references and discussion relating to other matters and the Q2 2017 results.

 

Dial-in details:

UK: 0800 694 8082

International: +44 (0) 1452 568 172

US: +1 866 966 8024

Conference ID: 54462050

 

Replay details:

UK FreeCall: 0800 953 1533

Std International: +44 (0)1452 550 000

USA FreeCall: +1 (866) 247 4222

Conference ID: 54462050

 

For further information, please contact:

 

RBS Investor Relations

+44 (0) 20 7672 1758

 

RBS Media Relations

+44 (0) 131 523 4205

 

Forward Looking StatementsThis announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to RBS and its subsidiaries' regulatory capital position, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBS's future economic results, business and capital plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK annual report and accounts and interim reports and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

MAR

 

This announcement contains information that qualified or may have qualified as inside information for the

purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR). For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Matt Waymark, Head of Investor Relations for The Royal Bank of Scotland Group.

 

LEI - The Royal Bank of Scotland Group plc - 2138005O9XJIJN4JPN90

LEI - The Royal Bank of Scotland plc - RR3QWICWWIPCS8A4S074

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUGWMUPMGPP
Date   Source Headline
30th May 20186:21 pmRNSResult of AGM
30th May 20181:55 pmRNSAGM Statement
30th May 201812:55 pmRNSDividend Declaration
30th May 20187:00 amRNSDirectorate Change
18th May 20181:23 pmRNSPublication of Suppl.Prospcts
16th May 201811:17 amRNSPricing of USD Fixed Rate to Floating Rate Notes
15th May 201812:44 pmRNSUpdate on ring-fencing plans
14th May 20182:00 pmRNSDirector/PDMR Shareholding
11th May 20183:18 pmRNSPublication of Suppl.Prospcts
10th May 201810:34 amRNSCapital reduction - notice of petition
10th May 20187:00 amRNSRBS settlement in principle with US DOJ on RMBS
2nd May 201812:38 pmRNSAlternative Remedies Package Deed signed
1st May 20186:12 pmRNSRBS notes credit ratings action by Fitch Ratings
1st May 20185:37 pmRNSPublication of Suppl.Prospcts
1st May 201812:00 pmRNSDirector/PDMR Shareholding
30th Apr 20185:08 pmRNSTotal Voting Rights
30th Apr 20182:40 pmRNSDirector/PDMR Shareholding
30th Apr 20187:00 amRNSRing-Fencing Transfer Scheme Effective
27th Apr 20187:02 amRNSRing Fenced Structure - Director Changes
27th Apr 20187:01 amRNSDirectorate Change
27th Apr 20187:00 amRNS1st Quarter Results
26th Apr 20183:04 pmRNSNotice of AGM
25th Apr 20181:00 pmRNSRBS Holdings N.V. & Royal Bank of Scotland N.V.
20th Apr 20184:35 pmRNSDividend Declaration
17th Apr 20186:07 pmRNSAllotment and Issue of New Ordinary Shares
17th Apr 20181:24 pmRNSMoU with Pension Trustee on ring-fencing alignment
13th Apr 201811:32 amRNSBlock listing Interim Review
11th Apr 20186:25 pmRNSPosting of Scheme Document
5th Apr 201812:00 pmRNSUpdate on ring-fencing plans
5th Apr 20187:00 amRNSRBS notes credit ratings action by Moody's
3rd Apr 20187:00 amRNSFILING OF ANNUAL REPORT ON FORM 20-F WITH US SEC
29th Mar 20185:45 pmRNSTotal Voting Rights
29th Mar 20181:19 pmRNSDirector/PDMR Shareholding
27th Mar 201810:15 amRNSRecommended cash offer
27th Mar 20189:59 amRNSRecommended Cash Offer for Freeagent Holdings PLC
26th Mar 20183:18 pmRNSAdditional Listing
23rd Mar 20185:09 pmRNSPublication of Suppl.Prospcts
22nd Mar 20183:21 pmRNSUpdate on ring fencing plans
20th Mar 20188:00 amRNSMorgan Stanley European Financials Conference
16th Mar 20182:37 pmRNSPublication of Final Terms
8th Mar 20184:02 pmRNSDirector/PDMR Shareholding
1st Mar 20186:10 pmRNSDividend Declaration
1st Mar 20183:10 pmRNSDirector/PDMR Shareholding
28th Feb 20186:27 pmRNSPublication of Final Terms
28th Feb 20186:20 pmRNSTotal Voting Rights
28th Feb 20181:37 pmRNSAdditional Listing
23rd Feb 20183:30 pmRNSPublication of Suppl.Prospcts
23rd Feb 20187:02 amRNSDirectorate Change
23rd Feb 20187:01 amRNSAnnual Financial Report
23rd Feb 20187:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.